Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
12 /100
LOW RISK
Score updated Aug 28, 2026

TAK — Takeda Pharmaceutical Company Limited Dilution Risk Tracker

Track TAK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TAK — Get alerts when the score changes →

As of August 28, 2026, Takeda Pharmaceutical Company Limited (TAK) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Takeda Pharmaceutical Company Limited has a market capitalization of $50.43B, 1.56B shares outstanding, 179 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TAK.
🔔 Track TAK — Get forecast alerts →

Market Data

Market Cap$50.43B
Shares Outstanding1.56B
Float1.58B
Cash$3.74B
Debt$34.24B
Short InterestN/A

Institutional Holdings

QoQ: ↑ 19.0% shares (2026Q1 vs prior)
179 institutional holders · 75.42M shares
#1 Frazier Life Sciences Management, L.P. 12.47M shares
#2 Medicxi Ventures Management (Jersey) Ltd 7.46M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 5.17M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.87M
Days to Cover1.0
% of Float0.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track TAK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TAK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TAK
TAK FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.